Replies to post #197027 on Avid Bioservices Inc (CDMO)

[pphmtoolong]

MazelMan, I don't think there is any doubt that Bavi works in the sense that it helps the immune system attack tumors. The question is does it work well enough to be a meaningful addition to the standard of care in one or more diseases.

Sunrise will tell us if Bavi works well enough to statistically and substantially extend the survival of lung cancer patients who failed the first line of treatment. Many us expect it will. If we are right, Peregrine with the help of Garnick will get FDA approval. Before or during the approval process Peregrine will get a good partnering deal or be bought out. In either case I would expect the share price to move up smartly.

Unless we partner sooner we will just have to wait for Sunrise.

GLTA, Paul

[The Other Guy]

Mazelman, It's not that simple. We have one trial that indicates bavi works. But that trial was sabotaged so there is a lack of certainty. We don't have enough information from management on the other trails for bavi's efficacy is validated. Management keeps expressing how excited they are about the trials. And they keep telling us to look forward to various events (look at the long potential catalyst list). And some of us have bought shares because of those comments. And although we may believe bavi does truly work, management has yet to provide follow up to many of their own statements. So it's not as easy as believing in bavi or not.